NASO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.894
EU - Europa 459
AS - Asia 341
AF - Africa 11
SA - Sud America 11
OC - Oceania 2
Totale 2.718
Nazione #
US - Stati Uniti d'America 1.873
SG - Singapore 145
IT - Italia 100
IN - India 89
DE - Germania 88
SE - Svezia 82
CN - Cina 77
FI - Finlandia 45
UA - Ucraina 40
RU - Federazione Russa 39
GB - Regno Unito 22
CA - Canada 17
TR - Turchia 10
AR - Argentina 9
TG - Togo 9
BE - Belgio 8
ID - Indonesia 7
IE - Irlanda 6
BG - Bulgaria 5
HK - Hong Kong 4
FR - Francia 3
RO - Romania 3
BR - Brasile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
CH - Svizzera 1
EE - Estonia 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 2.718
Città #
Fairfield 297
Chandler 159
Woodbridge 146
Houston 136
Ashburn 134
Wilmington 106
Seattle 102
Cambridge 100
Singapore 93
Ann Arbor 78
Princeton 56
Plano 40
San Paolo di Civitate 37
Lawrence 35
Santa Clara 35
Rome 34
Dearborn 30
Boston 28
Grafing 28
Beijing 23
Bremen 21
San Diego 21
Des Moines 19
Millbury 18
New York 15
Andover 14
Jacksonville 13
Falls Church 11
Fremont 11
Helsinki 10
Toronto 10
Istanbul 9
Lomé 9
Brussels 8
Federal 8
London 8
Yubileyny 8
Kunming 7
Moscow 7
Jakarta 6
Nanjing 6
Norwalk 6
Ottawa 6
Dublin 5
Milan 5
Sofia 5
Boardman 4
Catania 4
Delhi 4
Falkenstein 4
Hong Kong 4
Bühl 3
Guangzhou 3
Hefei 3
Indiana 3
Laurel 3
Phoenix 3
San Mateo 3
Shanghai 3
Wuhan 3
Zhengzhou 3
Belgrade 2
Chicago 2
Edinburgh 2
Fuzhou 2
Kilburn 2
Maia 2
Mannheim 2
Muizenberg 2
Naples 2
Panama City 2
Prague 2
Redwood City 2
Shenyang 2
Stockholm 2
Taganrog 2
Almaty 1
Amsterdam 1
Auckland 1
Bratislava 1
Caivano 1
Canuelas 1
Chengdu 1
Civitavecchia 1
Dallas 1
Dalmine 1
Dubai 1
Duncan 1
Florence 1
Genova 1
Gunzenhausen 1
Haifa 1
Hangzhou 1
Harbin 1
Ho Chi Minh City 1
Jinan 1
Lanzhou 1
Las Vegas 1
Leawood 1
Los Angeles 1
Totale 2.067
Nome #
A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer 116
PD-L1 expression in TNBC: a predictive biomarker of response to neoadjuvant chemotherapy? 113
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer. Pros and cons 98
Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors 93
Relationship and predictive role of the dual expression of FGFR and IL-8 in metastatic renal cell carcinoma treated with targeted agents 92
Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: Immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications 91
Adjuvant treatment of early breast cancer: do the St Gallen reccomandations influence clinical practice?Results from the NORA study 90
High frequency of human papillomavirus detection in urinary bladder cancer 87
Circulating tumor cells count and characterization in a male breast cancer patient 86
Detection of cellular heterogeneity by DNA ploidy, 17 chromosome, and p53 gene in primary carcinoma and metastasis in a case of ovarian cancer 86
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. 86
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey. 81
Detection of BCL-2 RNA in low grade tumours of the urinary bladder 79
Pancreatic cancer: From molecular signature to target therapy 78
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials 78
Chemoresistance profile of circulating tumor cells: Toward a clinical benefit? 76
Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology 75
Overcoming Endocrine Resistance in Breast Cancer 69
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide? 69
Circulating Tumor Cells in Cancer Therapy: Are we off Target? 68
Involvment of bcl-2 and bax gene expression in apoptosis and differentiation of the non-tumorigenic murine hematopoietic cell line, 32DCl3(G). 67
Management of Metastatic Renal Cell Carcinoma Progressed After Sunitinib or Another Antiangiogenic Treatment. 67
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 66
Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases 64
Follow-up in patients with BRCA mutations; focus on ovarian cancer risk : a single-center experience 62
Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: A phase I-II trial 61
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 53
Prognostic significance of survivin-expressing tumor cells in T1G3 bladder cancer 53
Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 51
How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment. 50
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in ER+/HERr2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 47
The promise of liquid biopsy in cancer: a clinical perspective 45
T-DM1 Efficacy in patients with HER2-positive metastatic breast cancer progressing after a Taxane Plus Pertuzumab and Trastuzumab. An italian multicenter observational study 44
Circulating tumor cells: highlight on practical implications. 43
Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo. 42
Biopsy of the thymus in patients with acquired immunodeficiency syndrome. 41
null 37
On chromosomal instability: what is the karyotype of your 32D CI3 cell line? 36
Incidence and risk of pulmonary toxicity in patients treated with mTOR ihibitors for malignancy. A meta-analysis of published trials 35
Oncotype DX predictive nomogram for recurrence score output: the novel system ADAPTED01 based on quantitative immunochemistry analysis 34
Linfoadenectomie del cavo ascellare nel cancro della mammella. 31
Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature 27
The Hemopoietic progenitor 32DCl3 (G) cells synthesize C3 molecules upon differentiation or neoplastic transformation 26
Selective radio-guided axillary dissection (SeRAD): A prospective cohort study 9
null 4
Totale 2.806
Categoria #
all - tutte 8.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 0 95 66 65 49 23 29
2020/2021198 21 22 9 13 4 16 4 13 16 45 17 18
2021/2022473 3 34 46 7 63 9 13 54 30 40 92 82
2022/2023580 105 111 23 79 64 65 11 34 49 3 29 7
2023/2024194 12 29 5 11 25 20 4 27 0 28 19 14
2024/2025251 12 39 27 32 56 51 34 0 0 0 0 0
Totale 2.806